Skip to main content
. 2017 Jul 6;8(51):89203–89213. doi: 10.18632/oncotarget.19038

Figure 4. Overall survival curves with time to recurrence for gastric cancer patients with local recurrence in patients not receiving palliative chemotherapy (A., P = 0.035), receiving palliative chemotherapy (B., P = 0.015), not receiving radiosensitizing chemotherapy (C., P = 0.062) and receiving radiosensitizing chemotherapy (D., P = 0.015).

Figure 4